EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies

Androulla N Miliotou iD, Andria Kotsoni, Lefteris C Zacharia iD

Biomolecules · 15.01.2025 · 15 (1) · 128

DOI: 10.3390/biom15010128 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 15.01.2025. Verfasst von Androulla N Miliotou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, 46 Makedonitissas Avenue, 2417 Nicosia, Cyprus. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, Adrenergic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are currently among the most devastating diseases with no effective disease-modifying drugs in the market, with Alzheimer’s disease (AD) being the most prevalent. AD is a complex multifactorial neurodegenerative disorder characterized by progressive and severe cognitive impairment and memory loss. It is the most common cause of progressive memory loss (dementia) in the elderly, and to date, there is no effective treatment to cure or slow disease progression substantially. The role of adrenergic receptors in the pathogenesis of Alzheimer’s disease and other tauopathies is poorly understood or investigated. Recently, some studies indicated a potential benefit of drugs acting on the adrenergic receptors for AD and dementias, although due to the heterogeneity of the drug classes used, the results on the whole remain inconclusive. The scope of this review article is to comprehensively review the literature on the possible role of adrenergic receptors in neurodegenerative diseases, stemming from the use of agonists and antagonists including antihypertensive and asthma drugs acting on the adrenergic receptors, but also from animal models and in vitro models where these receptors have been studied. Ultimately, we hope to obtain a better understanding of the role of these receptors, identify the gaps in knowledge, and explore the possibility of repurposing such drugs for AD, given their long history of use and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptors, AdrenergicHumansAnimals

Stichwörter der Autor:innen

Alzheimer’s diseaseadrenergic agonistsadrenergic antagonistsadrenergic receptorsbeta amyloidneurodegenerationneuroinflammationtauopathies

Substanzen

Receptors, Adrenergic

Autor:innen und Institutionen

  • Department of Health Sciences, School of Life and Health Sciences, University of Nicosia, 46 Makedonitissas Avenue, 2417 Nicosia, Cyprus.
  • Bioactive Molecules Research Center, School of Life and Health Sciences, University of Nicosia, 46 Makedonitissas Avenue, 2417 Nicosia, Cyprus.

ORCID-Profile: Androulla N Miliotou, Lefteris C Zacharia

Zitieren

APA

Miliotou, A. N., Kotsoni, A., & Zacharia, L. C. (2025). Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies. Biomolecules, 15(1), 128. https://doi.org/10.3390/biom15010128

Vancouver

Miliotou AN, Kotsoni A, Zacharia LC. Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies. Biomolecules. 2025;15(1):128. doi:10.3390/biom15010128

BibTeX
@article{Miliotou2025,
  author = {Miliotou, Androulla N and Kotsoni, Andria and Zacharia, Lefteris C},
  title = {Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {128},
  doi = {10.3390/biom15010128}
}
Kostenlos starten →